Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Driver, J. A.
Right arrow Articles by Kurth, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Driver, J. A.
Right arrow Articles by Kurth, T.
Related Collections
Right arrow Parkinson's disease/Parkinsonism
Right arrow Cohort studies
Right arrow Incidence studies
NEUROLOGY 2009;72:432-438
© 2009 American Academy of Neurology

Incidence and remaining lifetime risk of Parkinson disease in advanced age

Jane A. Driver, MD, MPH, Giancarlo Logroscino, MD, PhD, J. Michael Gaziano, MD, MPH and Tobias Kurth, MD, ScD

From the Divisions of Aging (J.A.D., J.M.G., T.K.) and Preventive Medicine (J.M.G., T.K.), Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Department of Neurology and Psychiatry (G.L.), School of Medicine, University of Bari, Italy; Department of Epidemiology (T.K.), Harvard School of Public Health, Boston, MA; and Massachusetts Veterans Epidemiology Research Information Center (J.M.G.), VA Boston Healthcare System, Boston, MA.

Address correspondence and reprint request to Dr. Jane A. Driver, Division of Aging, Brigham and Women's Hospital, 1620 Tremont St., Boston, MA 02120 jdriver{at}partners.org

Objective: To estimate the incidence and lifetime risk (LTR) of Parkinson disease (PD) in a large cohort of men.

Background: Age is the strongest risk factor for PD, but whether its incidence continues to increase after age 80 years remains unclear.

Methods: Prospective cohort of 21,970 US male physicians aged 40–84 years at baseline who did not report PD before study entry. Participants self-reported PD on yearly follow-up questionnaires, and all deaths were confirmed. We calculated incidence rates and cumulative incidence using a modified Kaplan–Meier analysis. LTR was estimated by adjusting cumulative incidence for competing risks of death.

Results: Five hundred sixty-three cases of PD were identified over 23 years of follow-up. The crude incidence rate of PD was 121 cases/100,000 person-years. Age-specific incidence rates increased sharply beginning at age 60 years, peaked in those aged 85–89 years, and declined beginning at age 90 years. Cumulative incidence substantially overestimated the long-term risk of PD, particularly in those aged 80 years and older. Cumulative incidence was 9.9% (95% confidence interval [CI] 8.48%–11.30%) from ages 45 to 100 years, whereas LTR for the same period was 6.7% (95% CI 6.01%–7.43%). The incidence and LTR of PD decreased with increasing exposure to smoking.

Conclusions: Our study provides evidence that the incidence of Parkinson disease (PD) in men increases through age 89 years. Whether the subsequent decline represents a true decrease in risk remains to be established. A history of smoking substantially decreased the incidence and lifetime risk of PD. Incidence studies that do not adjust for competing risks of death may overestimate the true risk of PD in the elderly.

Abbreviations: AD = Alzheimer disease; CI = confidence interval; LTR = lifetime risk; PD = Parkinson disease; PHS = Physicians' Health Study.


The Physicians' Health Study is supported by grants CA-34944, CA-40360, and CA-097193 from the National Cancer Institute and grants HL-26490 and HL-34595 from the National Heart, Lung, and Blood Institute, Bethesda, MD. J.A.D. is supported by a grant from the Parkinson's Disease Foundation.

Disclosure: Author disclosures are provided at the end of the article.

Received July 14, 2008. Accepted in final form October 24, 2008.




This article has been cited by other articles:


Home page
JAMAHome page
L. Djousse, J. A. Driver, and J. M. Gaziano
Relation Between Modifiable Lifestyle Factors and Lifetime Risk of Heart Failure
JAMA, July 22, 2009; 302(4): 394 - 400.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by AAN Enterprises, Inc.